Clinical Trials Browser

Phase 2 × Polycythemia Vera × Dasatinib × Clear all

Leukemia, Mastocytosis, Myelodysplastic Syndromes, Polycythemia Vera, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hypereosinophilic Syndrome, Primary Myelofibrosis

NCT00538980 2017-06-20

Dasatinib in Polycythemia Vera

Phase 2 Terminated

10 enrolled 7 charts

Myeloid

Polycythemia Vera

Clinical Trials

Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)

Dasatinib in Polycythemia Vera